|
Variable
|
Period
|
Age groups in years
|
P-value
|
|---|
|
≤5% (n)
|
6-10% (n)
|
11-14% (n)
|
|---|
|
Age group distribution
|
Baseline
|
53.5 (220)
|
32.6 (134)
|
13.9 (57)
| |
|
Follow-up
|
39.0 (177)
|
45.2 (205)
|
15.9 (72)
| |
|
Fever
|
Baseline
|
26.8 (59)
|
32.8 (44)
|
22.8 (13)
|
0.29
|
|
Follow-up
|
20.9 (37)
|
23.0 (47)
|
19.4 (14)
|
0.78
|
|
Malaria parasitaemia
|
Baseline
|
84.5 (186)
|
88.1 (118)
|
82.5 (47)
|
0.53
|
|
Follow-up
|
37.3 (66)
|
34.6 (71)
|
40.3 (29)
|
0.67
|
|
Gametocytaemia
|
Baseline
|
29.1 (64)
|
23.1 (31)
|
17.5 (10)
|
0.15
|
|
Follow-up
|
9.0 (16)
|
6.8 (14)
|
4.2 (3)
|
0.39
|
|
Splenomegaly
|
Baseline
|
31.8 (70)
|
15.7 (21)
|
10.5 (6)
|
<0.001c
|
|
Follow-up
|
12.4 (22)
|
12.7 (26)
|
23.6 (17)
|
0.049
|
|
CM
|
Baseline
|
23.6 (52)
|
29.1 (39)
|
21.1 (12)
|
0.39
|
|
Follow-up
|
10.7 (19)
|
8.8 (18)
|
8.3 (6)
|
0.76
|
|
AM
|
Baseline
|
60.9 (134)
|
59.0 (79)
|
61.4 (35)
|
0.92
|
|
Follow-up
|
22.6 (40)
|
22.4 (46)
|
30.6 (22)
|
0.34
|
|
Anaemia
|
Baseline
|
84.1 (185)
|
78.4 (105)
|
68.4 (39)
|
0.03a
|
|
Follow-up
|
37.9 (67)
|
28.8 (59)
|
6.9 (5)
|
<0.001c
|
|
MA
|
Baseline
|
73.2 (161)
|
66.4 (89)
|
59.6 (34)
|
0.103
|
|
Follow-up
|
20.3 (36)
|
14.1 (29)
|
1.4 (1)
|
<0.001c
|
- aSignificant at P <0.05 level, csignificant at P <0.001 level.
